Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Pharmacokinetic profile of ciclosporin derivative IMM-125

Nov. 18, 1997

Dainippon develops sustained-release morphine preparation

Nov. 18, 1997

Pharmacokinetic profile of Taisho's ACAT inhibitor

Nov. 18, 1997

New cardiotonic candidate studied, rejected at Fujisawa

Nov. 18, 1997

Potential of rhM-CIF in rheumatoid arthritis suggested by animal studies

Nov. 18, 1997

Celecoxib: safety and efficacy data presented at rheumatology meeting

Nov. 17, 1997

S-Nitrosocaptopril exerts both acute and chronic hypotensive effects in rats

Nov. 17, 1997

Development of tolerance to OPC-31260 effects in rats after chronic treatment

Nov. 17, 1997

D-19575: new cytostatic drug without renal side effects

Nov. 17, 1997

Antiatherosclerotic activity of Roche's benzodiazepine derivative Ro-11-1464 described

Nov. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...